The North American needle-free drug delivery devices market is expected to grow at a CAGR of around 14 % during the forecast period. The increasing need for self-administration of drugs as in the case of diseases such as diabetes and benefits offered by this technology such as pain-free drug delivery has enhanced the size of needle-free drug delivery devices industry.